Although serum ATG5 was not related to 1-year MMSE score decline (P=0.058) (Figure 3E), it was positively associated with 2-year (P=0.024) (Figure 3F) and 3-year (P=0.012) (Figure 3G) MMSE score decline in stroke patients. Here, ATG5 is linked to stroke disorder.